The term “vaccine” was coined by Louis Pasteur and derived from “Vacca”, meaning cow the term devised by Edward Jenner to denote cowpox. A vaccine is defined as a biological preparation that provides active acquired immunity to a particular disease and typically contains an agent that resembles a disease-causing microorganism and is often made from the exhaust or killed forms of the microbe, its toxins, or one of its surface proteins.
Vaccines have two major effects:
a) Vaccines protect individuals against disease.
b) If there are sufficient immune individuals in populations, the transmission of the infection is prevented. This is known as herd immunity.
Vaccine Design mainly includes the Production of vaccines and has several stages.
Firstly, the antigen itself is generated and Viruses are grown either on primary cells such as chicken eggs (e.g., for influenza), or on continuous cell lines such as cultured human cells (e.g., for hepatitis A). Bacteria are grown in bioreactors (e.g., haemophilic influenza type B).
Alternatively, a recombinant protein will be derived from the viruses or bacteria can be generated in yeast, bacteria, or cell cultures.
Strategies in vaccine design include:
Vaccine drug delivery system is the preparations given to patients to evoke immune responses that leading to the production of antibodies or cell-mediated responses that will help in combating infectious agents or non-infectious conditions such as malignancies.
The three categories of Vaccine delivery system include:
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand